Literature DB >> 30739156

Long-term follow-up of intraocular pressure and pressure-lowering medication in patients after ab-interno trabeculectomy with the Trabectome.

Markus Avar1, Jens F Jordan2, Matthias Neuburger3, Diana Engesser4, Jan Lübke4, Alexandra Anton4, Thomas Wecker4,5.   

Abstract

BACKGROUND: The minimally invasive ab-interno trabeculectomy (AIT) via electro-ablation with the Trabectome has been on the European market since 2009. Many studies have proven the safety and efficacy of the procedure. Up until now, studies investigating the long-term effect of AIT have been sparse. In this study, we present long-term results of AIT in patients with primary and secondary open-angle glaucoma.
METHODS: In a retrospective monocentric study, the data of all the patients having undergone the procedure in 2010 at our institution were recorded. Data was collected during routine examinations at our institution. In total, 81 eyes of 74 patients (46 patients with primary open-angle glaucoma (POAG), 28 patients with pseudoexfoliative glaucoma (PEXG)) were included. At every examination, the intraocular pressure (IOP) was measured using Goldmann applanation tonometry and the number of IOP-lowering medication was registered. Statistical analysis was done using the Kaplan-Meier analysis or Dunnett's t test, respectively.
RESULTS: For both groups (POAG and PEXG), we found a significant lowering of the IOP (28% for POAG and 26% for PEXG) and a significant reduction of the number of IOP-lowering medication (32% for POAG and 29% for PEXG) after a median follow-up period of 3.5 years.
CONCLUSION: In patients with open-angle glaucoma and especially pseudoexfoliative glaucoma, ab-interno trabeculectomy is an effective surgical procedure to significantly lower the intraocular pressure on a long-term basis.

Entities:  

Keywords:  Combined surgery; Glaucoma; Long-term results; MIGS; Trabectome

Mesh:

Substances:

Year:  2019        PMID: 30739156     DOI: 10.1007/s00417-019-04259-5

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  18 in total

1.  The prognostic value of the wuerzburg bleb classification score for the outcome of trabeculectomy.

Authors:  Thomas Klink; Gunda Kann; Patrick Ellinger; Janine Klink; Franz Grehn; Rainer Guthoff
Journal:  Ophthalmologica       Date:  2010-08-14       Impact factor: 3.250

Review 2.  Review and meta-analysis of ab-interno trabeculectomy outcomes.

Authors:  Kevin Kaplowitz; Igor I Bussel; Robert Honkanen; Joel S Schuman; Nils A Loewen
Journal:  Br J Ophthalmol       Date:  2016-01-05       Impact factor: 4.638

3.  [Trabeculectomy Ab Interno in Primary Open Angle Glaucoma and Exfoliative Glaucoma].

Authors:  M Pahlitzsch; J Gonnermann; A-K B Maier; N Torun; E Bertelmann; A M Joussen; M Klamann
Journal:  Klin Monbl Augenheilkd       Date:  2015-10-29       Impact factor: 0.700

4.  Trabeculectomy. Preliminary report of a new method.

Authors:  J E Cairns
Journal:  Am J Ophthalmol       Date:  1968-10       Impact factor: 5.258

5.  Three-year results of ab interno trabeculectomy (Trabectome): Berlin study group.

Authors:  Milena Pahlitzsch; Anja M Davids; Malte Zorn; Necip Torun; Sibylle Winterhalter; Anna-Karina B Maier; Matthias K Klamann; Eckart Bertelmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-12-30       Impact factor: 3.117

6.  A twenty-year follow-up study of trabeculectomy: risk factors and outcomes.

Authors:  John Landers; Keith Martin; Nicholas Sarkies; Rupert Bourne; Peter Watson
Journal:  Ophthalmology       Date:  2011-12-23       Impact factor: 12.079

7.  Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial.

Authors:  David F Garway-Heath; David P Crabb; Catey Bunce; Gerassimos Lascaratos; Francesca Amalfitano; Nitin Anand; Augusto Azuara-Blanco; Rupert R Bourne; David C Broadway; Ian A Cunliffe; Jeremy P Diamond; Scott G Fraser; Tuan A Ho; Keith R Martin; Andrew I McNaught; Anil Negi; Krishna Patel; Richard A Russell; Ameet Shah; Paul G Spry; Katsuyoshi Suzuki; Edward T White; Richard P Wormald; Wen Xing; Thierry G Zeyen
Journal:  Lancet       Date:  2014-12-19       Impact factor: 79.321

8.  Ab interno trabeculectomy: outcomes in exfoliation versus primary open-angle glaucoma.

Authors:  Jessica L M Ting; Karim F Damji; Michael C Stiles
Journal:  J Cataract Refract Surg       Date:  2012-02       Impact factor: 3.351

9.  The number of people with glaucoma worldwide in 2010 and 2020.

Authors:  H A Quigley; A T Broman
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

10.  Five-year clinical outcomes of combined phacoemulsification and trabectome surgery at a single glaucoma center.

Authors:  Hamed Esfandiari; Priyal Shah; Pooya Torkian; Ian P Conner; Joel S Schuman; Kiana Hassanpour; Nils A Loewen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-09-26       Impact factor: 3.117

View more
  5 in total

1.  Acute Closed-Angle Glaucoma-an Ophthalmological Emergency.

Authors:  Simone Nüssle; Thomas Reinhard; Jan Lübke
Journal:  Dtsch Arztebl Int       Date:  2021-11-12       Impact factor: 8.251

Review 2.  Effectiveness and limitations of minimally invasive glaucoma surgery targeting Schlemm's canal.

Authors:  Masayuki Kasahara; Nobuyuki Shoji
Journal:  Jpn J Ophthalmol       Date:  2020-11-05       Impact factor: 2.447

3.  Effect of Preoperative Intraocular Pressure in Patients with and without Intolerance to Their IOP-Lowering Medication on the Outcome of Trabectome Surgery.

Authors:  Juliana Wons; Nadine Mihic; Isabel B Pfister; Stefano Anastasi; Justus G Garweg; Markus Halberstadt
Journal:  Clin Ophthalmol       Date:  2021-05-06

4.  The Outcomes of Trabectome Surgery in Patients with Low, Middle, and High Preoperative Intraocular Pressure.

Authors:  Naoki Tojo; Atsushi Hayashi
Journal:  Clin Ophthalmol       Date:  2020-11-27

5.  The effects of antithrombotic therapy in ab interno trabeculotomy with a spatula-shaped microhook.

Authors:  Satoru Kanda; Takashi Fujishiro; Takashi Omoto; Ryosuke Fujino; Kiyoshi Ishii; Makoto Aihara
Journal:  PLoS One       Date:  2022-01-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.